iThriveMD review

What it is

iThriveMD is a longevity and metabolic-health clinic group with nine physical California locations — Encinitas, Eastlake, Carmel Valley, two in Mission Valley, Roseville, Walnut Creek, Sunnyvale and Laguna Niguel — plus telehealth. Its own locations page states "Telehealth across California and Arizona. Same member pricing, wherever you are." Its verticals are weight loss, hormone replacement, sexual health, peptide therapy, IV therapy, longevity and diagnostics. Published starting prices include sermorelin from $249, NAD⁺ injections and wafers from $249, GHK-Cu cream from $149, PT-141 from $199, glutathione from $45, methylene blue from $99, and testosterone replacement with enclomiphene from $289, each with a lower member rate.

How it works

Lab-driven and clinic-anchored, which is the substance of what you are buying. The practice describes a three-step method — measure, personalise, optimise — and states under the first step that there is in-depth diagnostic testing and baseline labs before any plan begins. For sermorelin that matters concretely: an IGF-1 baseline is the obvious thing to want before starting a growth-hormone secretagogue, and most of this board skips it entirely. Initial consultations are free, and having nine physical sites means the option of being seen in person rather than posting a vial. The commercial structure is the part to read carefully. Membership works as an unlock — the site's own framing is that starting one plan opens the whole menu — so the low member figures against each peptide are conditional on already being enrolled in a weight-loss or hormone program, and they run for 90 days. The gaps are sourcing and geography: no compounding pharmacy is named, no LegitScript or equivalent certification is displayed, and telehealth is limited to two states, which rules out most readers arriving at this page. Whether labs are billed inside or outside the quoted figures is not spelled out on the pricing pages.

Pricing transparency

Published for the molecules this board is about, which is uncommon enough to be the main reason to look. Sermorelin starts at $249, NAD⁺ injections and wafers at $249, GHK-Cu cream at $149, PT-141 at $199 and glutathione at $45, with member rates materially lower — $79 for sermorelin and NAD⁺, $59 for GHK-Cu, $49 for glutathione. On the hormone side, testosterone replacement with enclomiphene starts at $289, with a promotional rate advertised from $199.20 a month that carries the footnote "12-month program. Paid in full." That footnote is the reason we do not carry it as a monthly floor: a twelve-month prepay is a different financial commitment from a monthly rate, and it should not be compared against one. Nor do the peptide figures state a billing period on the pricing table, so ask whether $249 buys a month, a vial or a course. Ask too whether baseline labs are inside or outside the quoted price, what happens to the member rate after 90 days, and what the terms are if you stop the underlying plan that unlocked it.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The compounding pharmacy is not named and no LegitScript certification is displayed, and compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, the breadth of this menu is exactly why it should not be read as one longevity offer. Sermorelin acts on the growth-hormone axis, a real and well-described mechanism whose long-term human outcome data stays thin, with no controlled trial demonstrating the body-composition or recovery results it is marketed for. NAD⁺ by injection or wafer has no controlled human outcome trials at all; the oral precursors NR and NMN are the studied forms and raise blood NAD⁺, a biomarker rather than a benefit. Injectable glutathione and topical GHK-Cu have essentially no controlled human outcome evidence for the detox and skin-renewal claims attached to them. PT-141, or bremelanotide, is the outlier in the other direction — it has genuine human trial evidence and an approved product for hypoactive sexual desire disorder in premenopausal women, though a compounded version is not the approved product and the approval does not extend to general use. On the hormone side, testosterone therapy has a real evidence base together with real monitoring requirements and fertility suppression, and enclomiphene is offered here as part of the same protocol. Individual results vary.

Pros and watch-outs

The evidence behind what iThriveMD prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• GHK-Cu: the copper peptide between real skincare and overclaim

  A decades-deep molecule with a credible topical story — and systemic anti-aging claims that outrun the human data.

• PT-141 (bremelanotide): the evidence on a research-popular peptide that is actually FDA-approved

  Bremelanotide (Vyleesi) is FDA-approved for HSDD in premenopausal women, with phase-3 trial evidence. A straight read of what's proven — and where off-label use goes beyond it.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• TRT: what testosterone therapy is actually proven to do

  An FDA-approved therapy for diagnosed hypogonadism — with real but moderate benefits (sexual function, mood; not vitality), cardiovascular non-inferiority in TRAVERSE, and a real fertility trade-off.

• Enclomiphene: the evidence for restoring testosterone without replacing it

  Randomized trials, including two Phase III RCTs, show enclomiphene restores a man's own testosterone while preserving fertility — but it was never FDA-approved.

How iThriveMD compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Defy Medical

  The widest physician-supervised peptide menu with lab testing

  See Defy Medical →
• Invigor Medical

  Prescription at-home NAD⁺ injections via telehealth

  See Invigor Medical →
• SLSystem Labs

  NAD⁺ bundled with glutathione, B-12 and sermorelin from one service

  See System Labs →